Athira Pharma Inc (ATHA) Insider Trading
- $27,017,203.38
- $69,316.16
- Sept. 5, 2024
- Andrew Gengos
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 5, 2024 | CFO | 1,272 | $0.57 | Sell | $725.04 | |
| Sept. 5, 2024 | CEO | 5,032 | $0.57 | Sell | $2,868.24 | |
| Sept. 5, 2024 | COO | 2,525 | $0.57 | Sell | $1,439.25 | |
| June 24, 2024 | Director | 27,400 | $2.42 | Buy | $66,308.00 | |
| June 21, 2024 | Director | 15,000 | $2.26 | Buy | $33,900.00 | |
| Jan. 5, 2024 | CEO | 4,820 | $2.91 | Sell | $14,026.20 | |
| Jan. 5, 2024 | Insider | 1,208 | $2.91 | Sell | $3,515.28 | |
| Jan. 5, 2024 | General Counsel | 2,412 | $2.91 | Sell | $7,018.92 | |
| Dec. 29, 2023 | Director | 163,954 | $2.38 | Buy | $390,210.52 | |
| Dec. 27, 2023 | Director | 32,134 | $2.28 | Buy | $73,265.52 | |
| June 7, 2023 | Insider | 15,000 | $3.43 | Buy | $51,450.00 | |
| June 5, 2023 | Insider | 45,000 | $3.00 | Buy | $135,000.00 | |
| June 2, 2023 | Insider | 20,012 | $2.82 | Buy | $56,433.84 | |
| March 29, 2023 | Director | 5,000 | $2.40 | Buy | $12,000.00 | |
| Dec. 28, 2022 | CFO | 50,000 | $2.85 | Buy | $142,500.00 | |
| Dec. 2, 2022 | Director | 30,000 | $3.29 | Buy | $98,700.00 | |
| Nov. 15, 2022 | Insider | 5,000 | $3.29 | Buy | $16,450.00 | |
| June 29, 2022 | Director | 270,000 | $2.99 | Buy | $807,300.00 | |
| June 28, 2022 | Insider | 10,000 | $2.88 | Buy | $28,800.00 | |
| June 23, 2022 | CEO | 7,960 | $2.69 | Sell | $21,412.40 | |
| June 23, 2022 | General Counsel | 2,614 | $2.69 | Sell | $7,031.66 | |
| June 23, 2022 | COO | 4,193 | $2.69 | Sell | $11,279.17 | |
| March 31, 2022 | Director | 8,000 | $13.11 | Buy | $104,880.00 | |
| Jan. 25, 2021 | Director | 311,111 | $22.50 | Buy | $6,999,997.50 | |
| Sept. 22, 2020 | Director | 1,058,824 | $17.00 | Buy | $18,000,008.00 |
Insiders are both buying and selling Athira Pharma Inc stock.
The insider traders at Athira Pharma Inc are: Andrew Gengos, Kelly A Romano, Perceptive Advisors Llc, Mark James Litton, Mark Worthington, Rachel Lenington, Hans Moebius, Joseph Edelman, Glenna Mileson, and James A Johnson
The most active insider trader at Athira Pharma Inc is Andrew Gengos with 5 trades.
Mark James Litton has sold the most Athira Pharma Inc stock with a total value of $41,175.08.
Joseph Edelman has bought the most Athira Pharma Inc stock with a total value of $36,000,016.00.
The most recent insider trade for Athira Pharma Inc was on Sept. 5, 2024.
The single biggest insider buy for Athira Pharma Inc was from Joseph Edelman with a total value of $18,000,008.00 on Sept. 22, 2020.
The single biggest insider sell for Athira Pharma Inc was from Mark James Litton with a total value of $21,412.40 on June 23, 2022.